Results 101 to 110 of about 34,871 (236)
Radiopharmaceuticals for Diagnostics in Nuclear Medicine [PDF]
Bakalářská práce na téma Radiofarmaka pro diagnostiku v nukleární medicíně je rozdělena na dvě hlavní části. V první části jsem zpracoval teoretické informace o nukleární medicíně, radiofarmakách, radiační ochraně.
Vít Lajner
core
SINTESIS DAN KARAKTERISASI NUKLEOTIDA BERTANDA [α-32P]ATP
The utilization of nuclear technology in health sector with molecular techniques is increasingly developed today, especially in Indonesia. One of which is nucleotide compound marked with [α-32P]ATP, this compound has been used as tracer for ...
Wira Yusril Rahman +6 more
doaj +1 more source
Background and Purpose Oxidative stress plays a critical role in the pathophysiology of various diseases, yet current methods for its non‐invasive detection remain limited. This study aimed to systematically validate a superoxide‐selective PET tracer, [18F]FPBT, for the early diagnosis and therapeutic monitoring of oxidative stress‐related conditions ...
Hua Zhang +10 more
wiley +1 more source
Bone-seeking therapeutic radiopharmaceuticals [PDF]
Bone-seeking therapeutic radiopharmaceuticals are utilized on the basis of the radionuclide?s particulate emissions (primarily low to intermediate beta emission).
Srivastava Suresh C.
core
Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infections
Background The urgent demand for innovative theranostic strategies to combat bacterial resistance to antibiotics is evident, with substantial implications for global health. Rapid diagnosis of life-threatening infections can expedite treatment, improving
Jyotsna Bhatt Mitra +7 more
doaj +1 more source
The arginine-vasopressin (AVP) hormone plays a pivotal role in regulating various physiological processes, such as hormone secretion, cardiovascular modulation, and social behavior.
Junqi Hu +13 more
doaj +1 more source
ABSTRACT Introduction and Objective Treatment with sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) reduces the risk of both cardiovascular and renal outcomes in type 2 diabetes (T2D). The specific mechanism by which this happens has not yet been clarified.
Shawn Gugliandolo +18 more
wiley +1 more source
In vivo kinetics of radiopharmaceuticals - ADME [PDF]
This lecture deals with the pharmacokinetic aspects of Radiopharmaceuticals- absorption, distribution, metabolism and elimination (ADME)and the factors that influence these processes.
Smilkov, Katarina
core
Radioisotope 64Cu is a promising radiometallic-isotope for molecular-targeted-radiopharmaceuticals. Having a half-life of 12.70 hours and emitting β+-radiation (E+ = 0.6531 MeV) as well as β—ray (E = 0.5787 MeV), it is widely used in the form of ...
S. Soenarjo +5 more
doaj
Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?
Background Radiopharmaceuticals have been considered a special group of medicines in Europe since 1989. The use of radiopharmaceuticals that have marketing authorization should always be the first option in clinical use, however due to their special ...
Estrella Moya +3 more
doaj +1 more source

